Revenue | ₹3,643.16Cr |
Net Profits | ₹408.75Cr |
Net Profit Margins | 11.22% |
Mankind Pharma Ltd’s revenue jumped 10.87% since last year same period to ₹3,643.16Cr in the Q3 2025-2026. On a quarterly growth basis, Mankind Pharma Ltd has generated -3.91% fall in its revenue since last 3-months.
Mankind Pharma Ltd’s net profit jumped 7.5% since last year same period to ₹408.75Cr in the Q3 2025-2026. On a quarterly growth basis, Mankind Pharma Ltd has generated -20.09% fall in its net profits since last 3-months.
Mankind Pharma Ltd’s net profit margin fell -3.04% since last year same period to 11.22% in the Q3 2025-2026. On a quarterly growth basis, Mankind Pharma Ltd has generated -16.84% fall in its net profit margins since last 3-months.
The revenue for Mankind Pharma Ltd in the Q3 results 2025 was ₹3,643.16Cr.
The net profit for Mankind Pharma Ltd in the Q3 results 2025 was ₹408.75Cr.
The net profit margin for Mankind Pharma Ltd in the Q3 results 2025 was 11.22%.
The revenue for Mankind Pharma Ltd in the Q3 results 2024 was ₹3,285.88Cr.
The net profit for Mankind Pharma Ltd in the Q3 results 2024 was ₹380.23Cr.
The net profit margin for Mankind Pharma Ltd in the Q3 results 2024 was 11.57%.